{
    "10.1002_adhm.201800296.pdf": {
        "new materials": {
            "Yes/No": "No",
            "sentence": " DSPE-PEG2000 -DBCO (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[dibenzocyclooctyl(polyethylene glycol)-2000] (ammonium salt)) was purchased from Avanti Polar Lipids, Inc."
        },
        "screening algorithms": {
            "Yes/No": "No",
            "sentence": ""
        },
        "experimental methodology": {
            "Yes/No": "Yes",
            "sentence": " The current study developed a novel MNPs"
        },
        "ML algorithms": {
            "Yes/No": "No",
            "sentence": " None"
        },
        "models": {
            "Yes/No": "Yes",
            "sentence": " We developed a novel magnetic nanoprobe (MNP) surface functionalized with Zn2+-dipicolylamine (ZnDPA), which could selectively target phosphatidylserine (PS) on apoptotic cells and then amplify apoptosis-targeted T2-weighted magnetic resonance (MR) imaging in vivo."
        },
        "funding": {
            "Yes/No": "No",
            "sentence": " Not mentioned"
        },
        "material datasets": {
            "Yes/No": "No",
            "sentence": " None"
        },
        "drug formulations explored": {
            "Yes/No": "No",
            "sentence": " None"
        },
        "novel drug formulations": {
            "Yes/No": "Yes",
            "sentence": " MNPs"
        },
        "lead small-molecule drug candidates": {
            "Yes/No": "No",
            "sentence": " No sentence in the document mentions identifying to developing lead small-molecule drug candidates."
        },
        "clinical trials": {
            "Yes/No": "No",
            "sentence": "None"
        }
    }
}